|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200061504 |
|
最近更新日期: Date of Last Refreshed on: |
2022-06-27 15:29:26 |
|
注册时间: Date of Registration: |
2022-06-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中国急性脊髓损伤标志物队列的建立及应用研究 |
|
Public title: |
Development and Application of Chinese Marker Cohort for Acute Spinal Cord Injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中国急性脊髓损伤标志物队列的建立及应用研究 |
|
Scientific title: |
Development and Application of Chinese Marker Cohort for Acute Spinal Cord Injury |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王巍 |
研究负责人: |
冯世庆 |
|
Applicant: |
Wang Wei |
Study leader: |
Feng Shiqing |
|
申请注册联系人电话: Applicant telephone: |
18222992425 |
研究负责人电话:
Study leader's |
13920286292 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangweify@126.com |
研究负责人电子邮件: Study leader's E-mail: |
zhouhengxing@sdu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
天津市和平区鞍山道154号 |
研究负责人通讯地址: |
天津市和平区鞍山道154号 |
|
Applicant address: |
154 Anshan Road, Heping District, Tianjin, China |
Study leader's address: |
154 Anshan Road, Heping District, Tianjin, China |
|
申请注册联系人邮政编码: Applicant postcode: |
300052 |
研究负责人邮政编码: Study leader's postcode: |
300052 |
|
申请人所在单位: |
天津医科大学总医院 |
||
|
Applicant's institution: |
Tianjin Medical University General Hospital |
||
|
研究负责人所在单位: |
天津医科大学总医院 |
||
|
Affiliation of the Leader: |
Tianjin Medical University General Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
IRB2022-KY-292 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
天津医科大学总医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Tianjin Medical University General Hospital Medical Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-06-09 00:00:00 | ||
|
伦理委员会联系人: |
金冬来 |
||
|
Contact Name of the ethic committee: |
Jin Donglai |
||
|
伦理委员会联系地址: |
天津市和平区鞍山道154号天津医科大学总医院 |
||
|
Contact Address of the ethic committee: |
Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 022-60361044 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
天津医科大学总医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Tianjin Medical University General Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
天津市和平区鞍山道154号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
154 Anshan Road, Heping District, Tianjin, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
天津医科大学 |
||||||||||||||||||||||
|
Source(s) of funding: |
Tianjin Medical University |
||||||||||||||||||||||
|
研究疾病: |
脊髓损伤 |
||||||||||||||||||||||
|
Target disease: |
Spinal cord injury |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
1.建立多中心、大样本中国急性脊髓损伤标志物队列(队列数据库和生物样本数据库);2.评估急性脊髓损伤的管理现状,包括院前急救,诊断,治疗及康复,通过与现行指南的比较,找出存在缺陷的流程;3.通过系统规范的预后因子分析框架,评估血生化指标和急性脊髓损伤严重程度及预后之间的关联强度,开发早期预测急性脊髓损伤严重程度及预后的血生化标志物;4.遵循医学影像人工智能研究清单(CLAIM),通过机器学习建模,系统的评估影像学(如DTI-MRI)表现和急性脊髓损伤严重程度及预后之间的关联强度,开发早期预测急性脊髓损伤严重程度及预后的影像学标志物。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Establish a multi-centre, large-sample Chinese marker cohort (cohort and biological sample database) of acute spinal cord injury; 2. Assess current management of acute spinal cord injury, including pre-hospital care, diagnosis, treatment and rehabilitation, and then identify deficient procedures by comparing them with current guidelines; 3. Assess the association of blood biochemical indicators with the severity and prognosis of acute spinal cord injury through systematic and standardized prognostic factor analysis framework, and then develop blood biochemical markers for early prediction of the severity and prognosis of acute spinal cord injury; 4. Systematically assess the association of imaging (such as DTI-MRI) manifestations with the severity and prognosis of acute spinal cord injury through following Checklist for Artificial Intelligence in Medical Imaging (CLAIM) and machine learning modelling, and then develop imaging markers for early prediction of the severity and prognosis of acute spinal cord injury. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.急性期(2周内)脊髓损伤患者; |
||||||||||||||||||||||
|
Inclusion criteria |
1.Patients with spinal cord injury in acute stage (within 2 weeks); |
||||||||||||||||||||||
|
排除标准: |
1.既往存在神经肌肉病变的患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Patients with previous neuromuscular disease; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-09-01 00:00:00至 To 2025-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-09-01 00:00:00 至 To 2025-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
N/A |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
N/A |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
N/A |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
(1)数据录入 研究者根据受试者的原始观察记录,将数据及时、完整、正确、清晰地载入病例报告表。经过监察员审核、签字后的调查表应及时送交临床研究数据管理员。录入采用相应的数据库系统双人双机录入,之后对数据库进行两遍比对,期间若发现问题及时通知监查员,要求研究者做出回答。他们之间的各种疑问及解答的交换应当采用疑问表形式,疑问表应保存备查。 (2)数据核查 当所有病例报告表经双份输入并核对无误后,由数据管理员写出数据库检查报告,其内容包括研究完成情况(含脱落受试者清单)、入选/排除标准检查、完整性检查、逻辑一致性检查、离群数据检查、时间窗检查、合并用药检查、不良事件检查等。 在审核会议上,由主要研究者、申办单位代表、监查员、数据管理员和统计人员对数据库检查报告中提出的问题做出决议,写出审核报告,数据库同时将被锁定。 (3)数据存档 病例报告表在按要求完成数据录入和核查后,按编号的顺序归档保存,并填有检索目录等,以备查考。电子数据文件包括数据库、检查程序、分析程序、分析结果、编码本和说明文件等,应分类保存,并有多个备份保存于不同磁盘或记录介质上,妥善保存,防止损坏。所有原始档案应按相应规定内的期限保存。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
(1)Data Entry According to the original records of the participants, the researcher copies the data into the form timely, completely, correctly, and clearly. The questionnaire that is reviewed and signed by the inspector should be sent to the research data manager in time. The data entry is conducted by two independent researchers with two computers, and then the database is compared twice. If any problems are found during this period, the inspector will be notified in time, and the researcher will be asked to answer. The questions and answers between them should be recorded in tables, which are kept for future auditing. (2) Data verification After all forms have been double-entered and verified, the research data manager will write a database inspection report. Database inspection report includes research completion status (including list of participants dropped out), selection/exclusion criteria, completeness, logical consistency, outliers, time window, drug combination, adverse events, etc. At the review meeting, the main researchers, representatives of the sponsoring unit, inspectors, data administrators, and statisticians make resolutions on the issues raised in the database inspection report, write out the review report, and the database will be locked at the same time. (3) Data archiving After completing the data entry and verification, the data archive form is archived and saved in the order of numbering, and the retrieval directory is filled in for auditing. Electronic data files include database, inspection program, analysis program, analysis results, code and description files, etc. It should be classified and saved, and multiple backups should be saved on different disks or recording media to properly save and prevent damage. All original files shall be kept within the corresponding time limit. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |